BCL6 and hepatocellular carcinoma: By analyzing these TFs association with HCC patient clinical outcome including overall survival (OS), Progression-free survival (PFS) and Recurrence free survival using KM-plot17, we found BCL6 was associated with worse clinical outcome compared to other 7 TFs (Fig. 1f, g and Fig. S1a, S1b).